Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-16

Clinical Trial Update: Whole Grain Job's Tear, Muscle Health, Blood Glucose and Lipid Level [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating a whole-grain Job's tears supplement for muscle health and metabolic parameters in sarcopenia and frailty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Whole Grain Job's Tear Supplement (Coix lacryma-jobi (Job's tears) extract)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Sarcopenia, Frailty | Phase 2 | Status: RECRUITING